Muscle relaxants in burns, trauma, and critical illness

International Anesthesiology Clinics

Volumn 44, Issue 2, 2006, Pages 123-143

  Jeevendra Martyn, J A ^a   Fukushima, Yuji ^b   Chon, Jin Young ^c   Yang, Hong Seuk ^d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c The Catholic University of Korea   (South Korea)

^d University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ATRACURIUM; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BOTULINUM TOXIN; BUNGAROTOXIN; CALCIUM CHLORIDE; CALCIUM SALT; CHOLINE; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; CISATRACURIUM; COBROTOXIN; CONOTOXIN; DIMETHYLTUBOCURARINE CHLORIDE; GLUCONATE CALCIUM; MAGNESIUM SULFATE; MIVACURIUM; MUSCLE RELAXANT AGENT; NARCOTIC AGENT; NICOTINE; NICOTINIC RECEPTOR; PANCURONIUM; ROCURONIUM; SUXAMETHONIUM; TETANUS TOXIN; TUBOCURARINE CHLORIDE; UNINDEXED DRUG; VECURONIUM; NEUROMUSCULAR BLOCKING AGENT;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; BRADYCARDIA; BURN; CRITICAL ILLNESS; ENDOTRACHEAL INTUBATION; HEART ARREST; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOTENSION; HYPOVENTILATION; HYPOXEMIA; INJURY; LARYNX SPASM; MUSCLE ATROPHY; PARALYSIS; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; REVIEW; TACHYCARDIA; ARTIFICIAL VENTILATION; CHEMICALLY INDUCED DISORDER; PHYSIOLOGY;

BURNS; CRITICAL ILLNESS; HUMANS; HYPERKALEMIA; INTUBATION, INTRATRACHEAL; NEUROMUSCULAR NONDEPOLARIZING AGENTS; RECEPTORS, NICOTINIC; RESPIRATION, ARTIFICIAL; SUCCINYLCHOLINE; WOUNDS AND INJURIES;

EID: 33746829680     PISSN: 00205907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004311-200604420-00008     Document Type: Review

References (79)

1. Ward PA. Immunosuppression after trauma. Crit Care Med. 2005;33:1453-1454.
2. Mort TC. Preoxygenation in critically ill patients requiring emergency tracheal intubation. Crit Care Med. 2005;33:2672-2675.
3. Sakles JC, Laurin EG, Rantapaa AA, et al. Airway management in the emergency department: a one-year study of 610 tracheal intubations. Ann Emerg Med. 1998;31:325-332.
4. Norwood S, Myers MB, Butler TJ. The safety of emergency neuromuscular blockade and orotracheal intubation in the acutely injured trauma patient. J Am Coll Surg. 1994;179:646-652.
5. Syverud SA, Borron SW, Storer DL, et al. Prehospital use of neuromuscular blocking agents in a helicopter ambulance program. Ann Emerg Med. 1988;17:236-242.
6. Ma OJ, Atchley RB, Hatley T, et al. Intubation success rates improve for an air medical program after implementing the use of neuromuscular blocking agents. Am J Emerg Med. 1998;16:125-127.
7. Bulger EM, Copass MK, Sabath DR, et al. The use of neuromuscular blocking agents to facilitate prehospital intubation does not impair outcome after traumatic brain injury. J Trauma. 2005;58:718-724.
8. Schwartz DE, Matthay MA, Cohen NH. Death and other complications of emergency airway management in critically ill adults. Anesthesiology. 1995;82:367-376.
9. Lowenstein E, Hallowell P, Levine FH, et al. Cardiovascular response to large doses of intravenous morphine in man. N Engl J Med. 1969;281:1389-1393.
10. Stanley TH, Philbin DM, Coggins CH. Fentanyl-oxygen anaesthesia for coronary artery surgery: cardiovascular and antidiuretic hormone responses. Can Anaesth Soc J. 1979;26:168-172.
11. Raja SN, Lowenstein E. The birth of opioid anesthesia. Anesthesiology. 2004;100:1013-1015.
12. Topulos GP. Neuromuscular blockade in adult intensive care. New Horiz. 1993;1:447-462.
13. Topulos GP, Lansing RW, Banzett RB. The experience of complete neuromuscular blockade in awake humans. J Clin Anaesth. 1993;5:369-374.
14. Loper KA, Butler S, Nessly M, et al. Paralyzed with pain: the need for education. Pain. 1989;37:315-316.
15. Coggeshall JW, Marini JJ, Newman JH. Improved oxygenation after muscle relaxation in adult respiratory distress syndrome. Arch Intern Med. 1985;145:1718-1720.
16. Gainnier M, Roch A, Forel JM, et al. Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome. Crit Care Med. 2004;32:113-119.
17. Marik PE, Kaufman D. The effects of neuromuscular paralysis on systemic and splanchnic oxygen utilization in mechanically ventilated patients. Chest. 1996;109:1038-1042.
18. Vernon DD, Witte MK. Effect of neuromuscular blockade on oxygen consumption and energy expenditure in sedated, mechanically ventilated children. Crit Care Med. 2000;28:1569-1571.
19. Barton RG, Craft WB, Mone MC, et al. Chemical paralysis reduces energy expenditure in patients with burns and severe respiratory failure treated with mechanical ventilation. J Burn Care Rehabil. 1997;18:461-468.
20. Field S, Kelly SM, Macklem PT. The oxygen cost of breathing in patients with cardiorespiratory disease. Am Rev Respir Dis. 1982;126:9-13.
21. Tobin MJ. Mechanical ventilation. N Engl J Med. 1994;330:1056-1061.
22. Werba A, Klezl M, Schramm W, et al. The level of neuromuscular block needed to suppress diaphragmatic movement during tracheal suction in patients with raised intracranial pressure: a study with vecuronium and atracurium. Anaesthesia. 1993;48:301-303.
23. Vachon CA, Warner DO, Bacon DR. Succinylcholine and the open globe. Anesthesiology. 2003;99:220-223.
24. Martyn JAJ, White DA, Gronert GA, et al. Up-and-down regulation of skeletal muscle acetylcholine receptors. Effects on neuromuscular blockers. Anesthesiology. 1992;76:822-844.
25. Martyn JAJ, Richtsfeld M. Succinylcholine-induced hyperkalemia in acquired pathologic states: etiological factors and molecular mechanisms. Anesthesiology. 2006;104:158-169.
26. Coursin DB, Klasek G, Goelzer SL. Increased requirements for continuously infused vecuronium in critically ill patients. Anesth Analg. 1989;69:518-521.
27. Callanan DL. Development or resistance to pancuronium in adult respiratory distress syndrome. Anesth Analg. 1985;64:1126-1128.
28. Askmark H, Backman E, Gillberg PG, et al. Quantification of extrajunctional acetylcholine receptors in human muscle biopsies. Acta Neurol Scand. 1991;83:259-261.
29. Antognini J, Gronert GA. Succinylcholine causes profound hyperkalemia in hemorrhagic, acidotic rabbits. Anesth Analg. 1993;77:585-588.
30. Lindstrom JM. Nicotnic acetylcholine receptors of muscles and nerves. Comparison of their structures, functional roles, and vulnerability to pathology. Ann N Y Acad Sci. 2003;998:41-52.
31. Tsuneki H, Salas R, Dani JA. Mouse muscle denervation increases expression of an alpha7 nicotinic receptor with unusual pharmacology. J Physiol. 2003;15:169-179.
32. Fischer U, Reinhardt S, Albuquerque EX, et al. Expression of functional alpha7 nicotinic acetylcholine receptor during mammalian muscle development and denervation. Eur J Neurosci. 1999;11:2856-2864.
33. Fambrough DM. Control of acetylcholine receptors in skeletal muscle. Physiol Rev. 1979;59:165-227.
34. Witzemann V, Brenner HR, Sakmann B. Neural factors regulate AChR subunit mRNAs at rat neuromuscular synapses. J Cell Biol. 1991;114:125-141.
35. Fahim MA. Rapid neuromuscular remodeling following limb immobilization. Anat Rec. 1989;224:102-109.
36. Ibebunjo C, Martyn JAJ. Fiber atrophy, but not changes in acetylcholine receptor expression, contributes to the muscle dysfunction after immobilization. Crit Care Med. 1999;27:275-285.
37. Yanez P, Martyn JAJ. Prolonged d-tubocurarine infusion and/or immobilization cause upregulation of acetylcholine receptors and hyperkalemia to succinylcholine in rats. Anesthesiology. 1996;84:384-391.
38. Hogue CW Jr, Ward JM, Itani MS, et al. Tolerance and upregulation of acetylcholine receptors follow chronic infusion of d-tubocurarine. J Appl Physiol. 1992;72:1326-1331.
39. Markewitz BA, Elstad MR. Succinylcholine-induced hyperkalemia following prolonged pharmacologic neuromuscular blockade. Chest. 1997;111:248-250.
40. Kim C, Hirose M, Martyn JAJ. d-Tubocurarine accentuates the burn-induced upregulation of nicotinic acetylcholine receptors at the muscle membrane. Anesthesiology. 1995;83:309-315.
41. Gu Y, Franco A Jr, Gardner PD, et al. Properties of embryonic and adult muscle acetylcholine receptors transiently expressed in COS cells. Neuron 1990;5:147-157.
42. Yost CS, Winegar BD. Potency of agonists and competitive antagonists on adult- and fetal-type nicotinic acetylcholine receptors. Cell Mol Neurobiol. 1997;17:35-50.
43. Jonsson M, Ericksson L. Activation and inhibition of human muscle and neuronal nicotinic acetylcholine receptors by succinylcholine. Anesthesiology. In press.
44. Placzek AN, Grassi FK, Papke T, et al. A single point mutation confers properties of the muscle-type nicotinic acetylcholine receptor to homomeric α7 receptors. Mol Pharmacol. 2002;66:169-177.
45. Hall ZW. Synaptic structure and development: the neuromuscular junction. Neuron. 1993;10:99-121.
46. Tansey MG, Chu GC, Merlie JP. ARIA/HRG regulates AChR epsilon subunit gene expression at the neuromuscular synapse via activation of phosphatidylinositol 3-kinase and Ras/MAPK pathway. J Cell Biol. 1996;134:465-476.
47. Ikezu T, Okamoto T, Yonezawa K, et al. Analysis of thermal injury-induced insulin resistance in rodents: implication of post-receptor mechanism. J Biol Chem. 1997;272:25289-25295.
48. Hirose M, Kaneki M, Sugita H, et al. Immobilization depresses insulin signaling in skeletal muscle. Am J Physiol Endocrinol Metab. 2000;279:235-241.
49. Hirose M, Kaneki M, Sugita H, et al. Long-term denervation impairs insulin receptor substrate-1-mediated insulin signaling in skeletal muscle. Metabolism. 2001;50:216-222.
50. Sugita H, Kaneki M, Sugita M, et al. Burn injury impairs insulin-stimulated Akt/PKB activation in skeletal muscle. Am J Physiol Endocrinol Metab. 2005;288:E585-E591.
51. Ibebunjo C, Martyn JA. Thermal injury induces greater resistance to d-tubocurarine in local rather than in distant muscles in the rat. Anesth Analg. 2000;91:1243-1249.
52. Ibebunjo C, Nosek MT, Itani MS, et al. Mechanisms for the paradoxical resistance to d-tubocurarine during immobilization-induced muscle atrophy. J Pharmacol Exp Ther. 1997;283:443-451.
53. Hogue CW Jr, Itani MS, Martyn JAJ. Resistance to d-tubocurarine in lower motor neuron injury is related to increased acetylcholine receptors at the neuromuscular junction. Anesthesiology. 1990;73:703-709.
54. Marshall CG, Ogden DC, Colquhoun D. The actions of suxamethonium (succinyldicholine) as an agonist and channel blocker at the nicotinic receptor of frog muscle. J Physiol. 1990;428:155-174.
55. Kenakin TP. Pharmacological Analysis of Drug-receptor Interaction. NY: Raven Press; 1993.
56. Wonnacott S. The paradox of nicotinic acetylcholine receptor upregulation by nicotine. Trends Pharmacol Sci. 1990;11:216-219.
57. Latronico N, Peli E, Botteri M. Critical illness myopathy and neuropathy. Curr Opin Crit Care. 2005;11:126-132.
58. Bednarik J, Vondracek P, Dusek L, et al. Risk factors for critical illness polyneuromyopathy. J Neurol 2005;252:343-351.
59. Ibebunjo C, Martyn J. Disparate dysfunction of skeletal muscles located near and distant from burn site in the rat. Muscle Nerve. 2001;24:1283-1294.
60. Sakaba T, Stein A, Jahn R, et al. Distinct kinetic changes in neurotransmitter release after SNARE protein cleavage. Science. 2005;309:491-494.
61. Turton K, Chaddock JA, Acharya KR. Botulinum and tetanus neurotoxins: structure, function and therapeutic utility. Trends Biochem Sci. 2002;27:552-558.
62. Martyn JAJ, Matteo RS, Greenblatt DJ, et al. Pharmacokinetics of d-tubocurarine in patients with thermal injury. Anesth Analg. 1982;61:241-246.
63. Martyn JAJ. Clinical pharmacology and drug therapy in the burned patient. Anesthesiology. 1986;65:67-75.
64. Leibel WS, Martyn JAJ, Szyfelbein SK, et al. Elevated plasma binding cannot account for the burn-related d-tubocurarine hyposensitivity. Anesthesiology. 1981;54:378-382.
65. Martyn JAJ, Abernethy DR, Greenblatt DJ. Plasma protein binding of drugs after severe burn injury. Clin Pharmacol Ther. 1984;35:535-539.
66. Gronert GA, Theye RA. Pathophysiology of hyperkalemia induced by succinylcholine. Anesthesiology. 1975;43:89-99.
67. Szerlip HM, Weiss J, Singer I. Profound hyperkalemia without electrocardiographic manifestations. Am J Kidney Dis. 1986;7:461-465.
68. Evans K, Reddan DN, Szczech LA. Nondialytic management of hyperkalemia and pulmonary edema among end-stage renal disease patients: an evaluation of the evidence. Semin Dial. 2004;17:22-29.
69. Gronert GA, Lambert EH, Theye RA. The response of denervated skeletal muscle to succinylcholine. Anesthesiology. 1973;39:13-22.
70. Fink H, Blobner M, Martyn JAJ. Neuromuscular blocking drugs and reversal drugs Anesthetic. In: Evers AS, Maze M, eds. Pharmacolology Physiological Principles and Clinical Practice. NY: Churchill Livingstone; 2004:573-620.
71. Welch RM, Brown A, Ravitch J, et al. The in vitro degradation of cisatracurium, the R, cis-R'-isomer of atracurium, in human and rat plasma. Clin Pharmacol Ther. 1995;58:132-142.
72. Kamolz LP, Andel H, Greher M, et al. Serum cholinesterase activity reflects morbidity in burned patients. Burns. 2002;28:147-150.
73. Martyn JAJ, Goudsouzian NG, Chang Y, et al. Neuromuscular effects of mivacurium in 2- to 12-yr-old children with burn injury. Anesthesiology. 2000;92:31-37.
74. Martyn JAJ, Chang Y, Goudsouzian NG, et al. Pharmacodynamics of mivacurium chloride in 13- to 18-year-old adolescents with thermal injury. Br J Anaesth. 2002;89:580-585.
75. Hagen J, Martyn J, Szyfelbein SK, et al. Cardiovascular and neuromuscular responses to high-dose pancuronium-metocurine in pediatric burned and reconstructive patients. Anesth Analg. 1986;65:1340-1344.
76. Sluga M, Ummenhofer W, Studer W, et al. Rocuronium versus succinylcholine for rapid sequence induction of anesthesia and endotracheal intubation: a prospective, randomized trial in emergent cases. Anesth Analg. 2005;101:1356-1361.
77. Han T, Kim H, Bae J, et al. Neuromuscular pharmacodynamics of rocuronium in patients with major burns. Anesth Analg. 2004;99:386-392.
78. Hosking MP, Lennon RL, Gronert GA. Combined H1 and H2 receptor blockade attenuates the cardiovascular effects of high-dose atracurium for rapid sequence endotracheal intubation. Anesth Analg. 1988;67:1089-1092.
79. Kim C, Martyn J, Fuke N. Burn injury to trunk of rat causes denervation-like responses in the gastrocnemius muscle. J Appl Physiol. 1988;65:745-751